Clinical & scientific operations case studies
How we provide innovative solutions to ensure accurate data, regulatory compliance, and patient safety
Maximising patient recruitment and retention, and expanding access to diverse patient populations.
We work with you to develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to make data-driven decisions for every study.
Transforming post-marketing safety operations
ICON partnered with a top 10 global pharmaceutical company to support its post-marketing pharmacovigilance
(PV) operations. The partnership evolved from a traditional service model into a fully embedded, strategic
collaboration focused on continuous improvement, cost savings, and global harmonisation.
(PV) operations. The partnership evolved from a traditional service model into a fully embedded, strategic
collaboration focused on continuous improvement, cost savings, and global harmonisation.
Scaling safety operations for a first-in-market launch
ICON partnered with a leading BioPharma company to support pharmacovigilance (PV) operations for a novel indication product. Following six years of collaboration during clinical development, ICON transitioned to post-marketing support upon product approval and launch in the US and EU.
Affiliate level solution
A mid-size pharmaceutical company with numerous affiliates and local vendors across 80 countries sought a reliable partner for effective Pharmacovigilance (PV) and Medical Information (MI) services.
Safety reporting continuity to protect patient safety and maintain compliance
Scientists are working diligently to learn more about the Coronavirus and health boards are changing guidance to adapt to
this newly available information.
this newly available information.
The ICON safety reporting solution
ICON's Safety Reporting Solution ensured regulatory compliance during global trials by adapting to pandemic-related disruptions.
Prioritising efficiency and flexibility in safety data signal detection
ICON collaborated with a small US-based pharmaceutical company to conduct safety signal detection and management during the clinical development of four neurodegenerative disease compounds, using SIGNET.
Strategic blended solution across multiple services for global upscale
A large pharma partner required a blended solutions to support significant upscale across clinical operations, pharmacovigilance and data science.